L-779976

1H-吲哚-3-丙酰胺,N-[[(1R,3S)-3-(氨基甲基)环己基]甲基]-α-[[[[4-(2,3-二氢-2-氧索-1H-苯并咪唑-1-基)-1-哌啶基]氨基]-β甲基,(αR,βS)-Chemical Name: N1-[3(S)-(Aminomethyl)-1(R)-cyclohexylmethyl]-N2-[4-(2-oxobenzimidazolin-1-yl)piperidin-1-ylcarbonyl]-3(S)-methyl-D-tryptophanamide
CAS No. 214770-19-1
项目整合开发状态: Preclinical
项目研究机构: Merck & Co. (Originator)
合成路线:Synthesis of intermediate (VIII): Hydrogenation of m-cyanobenzoic acid (I) with H2 over Raney-Ni in ammonia gives amine (II),which is treated with Boc2O and NaOH in dioxane to provide protected amine (III).Reduction of (III) by means of PtO2 and H2 in acetic acid yields a 10:1 mixture of cis/trans ciclohexane derivatives (rac)-(IV)/(rac)-(V).The racemic cis compound obtained is enantiomerically resolved and stereomer (V) is then reduced with BH3.Me2S in THF providing alcohol (VI),which is converted into azide (VII) after treatment with NaN3 in DMF of the mesylate derivative obtained by treatment of (VI) with Et3N,DMAP and MsCl.Finally amino derivative (VIII) is obtained by hydrogenation of azide (VII) over Pd/C in MeOH.Synthesis of intermediate (XII): beta-Methyl-D-tryptophan methyl ester (IX) reacts with piperidine derivative (X) in presence of DSC and DIEA in CH2Cl2 to afford (XI),whose methyl ester is hydrolyzed in THF with LiOH in EtOH/H2O.Synthesis EN 269873: Finally intermediate (XII) is coupled with (VIII) with EDC and HOBt,and the Boc group is removed with TFA in CH2Cl2 to yield the desired product.